|
AP2883c-ev
|
Abcepta, Inc.
|
CD36 [Centre] [RB19992], Rabbit Polyclonal Antibody
|
Mouse
|
WB, IF, FC, IHC-P
|
|
|
AP2883c
|
Abcepta, Inc.
|
CD36 [Centre] [RB19992], Rabbit Polyclonal Antibody
|
Mouse
|
WB, IF, FC, IHC-P
|
|
|
AP10680C-ev
|
Abcepta, Inc.
|
HP [Centre] [RB28443], Rabbit Polyclonal Antibody
|
Human, Mouse
|
IHC-P-Leica, WB, IF, FC
|
|
|
AP10680C
|
Abcepta, Inc.
|
HP [Centre] [RB28443], Rabbit Polyclonal Antibody
|
Human, Mouse
|
IHC-P-Leica, WB, IF, FC
|
|
|
ATGP3592-250ug
|
NKMax Bio (ATGen)
|
Glycophorin A [20-91 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3592-50ug
|
NKMax Bio (ATGen)
|
Glycophorin A [20-91 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
AM32474PU-N
|
OriGene Technologies
|
Plasmodium falciparum Histidine Rich Protein-2 (HRP2) [B1242M], Mouse Monoclonal Antibody
|
Plasmodium falciparum
|
ELISA, LF
|
|
|
AM32476PU-N
|
OriGene Technologies
|
Plasmodium falciparum Histidine Rich Protein-2 (HRP2) [B1243M], Mouse Monoclonal Antibody
|
Plasmodium falciparum
|
ELISA, LF
|
|
|
AM32475PU-N
|
OriGene Technologies
|
Plasmodium falciparum Histidine Rich Protein-2 (HRP2) [B1245M], Mouse Monoclonal Antibody
|
Plasmodium falciparum
|
ELISA, LF
|
|
|
HY-103397-10mg
|
MedChemexpress LLC
|
Nanaomycin A [CAS 52934-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103397-25mg
|
MedChemexpress LLC
|
Nanaomycin A [CAS 52934-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103397-5mg
|
MedChemexpress LLC
|
Nanaomycin A [CAS 52934-83-5]
|
|
Cancer-programmed cell death
|
|
|
HY-17036-10mg
|
MedChemexpress LLC
|
Naphthoquine (phosphate) [CAS 173531-58-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-17036-100mg
|
MedChemexpress LLC
|
Naphthoquine (phosphate) [CAS 173531-58-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-17036-5mg
|
MedChemexpress LLC
|
Naphthoquine (phosphate) [CAS 173531-58-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-17036-50mg
|
MedChemexpress LLC
|
Naphthoquine (phosphate) [CAS 173531-58-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-17036-500mg
|
MedChemexpress LLC
|
Naphthoquine (phosphate) [CAS 173531-58-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-N8060A-1mg
|
MedChemexpress LLC
|
Orotidine 5?-monophosphate (trisodium) [CAS 68244-58-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N8060A-5mg
|
MedChemexpress LLC
|
Orotidine 5?-monophosphate (trisodium) [CAS 68244-58-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-135648-1mg
|
MedChemexpress LLC
|
PfDHODH-IN-1 [CAS 183945-55-3]
|
|
COVID-19-anti-virus
|
|
|
HY-135648-10mg
|
MedChemexpress LLC
|
PfDHODH-IN-1 [CAS 183945-55-3]
|
|
COVID-19-anti-virus
|
|
|
HY-135648-25mg
|
MedChemexpress LLC
|
PfDHODH-IN-1 [CAS 183945-55-3]
|
|
COVID-19-anti-virus
|
|
|
HY-135648-5mg
|
MedChemexpress LLC
|
PfDHODH-IN-1 [CAS 183945-55-3]
|
|
COVID-19-anti-virus
|
|
|
HY-135648-50mg
|
MedChemexpress LLC
|
PfDHODH-IN-1 [CAS 183945-55-3]
|
|
COVID-19-anti-virus
|
|
|
HY-W078844-10mg
|
MedChemexpress LLC
|
PfDHODH-IN-2 [CAS 425629-94-3]
|
|
COVID-19-immunoregulation
|
|
